1. Home
  2. ALLR vs DLPN Comparison

ALLR vs DLPN Comparison

Compare ALLR & DLPN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ALLR
  • DLPN
  • Stock Information
  • Founded
  • ALLR 2004
  • DLPN 1996
  • Country
  • ALLR United States
  • DLPN United States
  • Employees
  • ALLR N/A
  • DLPN N/A
  • Industry
  • ALLR Biotechnology: Pharmaceutical Preparations
  • DLPN Other Consumer Services
  • Sector
  • ALLR Health Care
  • DLPN Consumer Discretionary
  • Exchange
  • ALLR Nasdaq
  • DLPN Nasdaq
  • Market Cap
  • ALLR 13.3M
  • DLPN 11.9M
  • IPO Year
  • ALLR N/A
  • DLPN N/A
  • Fundamental
  • Price
  • ALLR $1.00
  • DLPN $1.13
  • Analyst Decision
  • ALLR
  • DLPN Strong Buy
  • Analyst Count
  • ALLR 0
  • DLPN 1
  • Target Price
  • ALLR N/A
  • DLPN $5.00
  • AVG Volume (30 Days)
  • ALLR 464.0K
  • DLPN 27.9K
  • Earning Date
  • ALLR 08-04-2025
  • DLPN 08-13-2025
  • Dividend Yield
  • ALLR N/A
  • DLPN N/A
  • EPS Growth
  • ALLR N/A
  • DLPN N/A
  • EPS
  • ALLR N/A
  • DLPN N/A
  • Revenue
  • ALLR N/A
  • DLPN $48,618,803.00
  • Revenue This Year
  • ALLR N/A
  • DLPN $6.57
  • Revenue Next Year
  • ALLR N/A
  • DLPN $18.10
  • P/E Ratio
  • ALLR N/A
  • DLPN N/A
  • Revenue Growth
  • ALLR N/A
  • DLPN 0.31
  • 52 Week Low
  • ALLR $0.61
  • DLPN $0.75
  • 52 Week High
  • ALLR $7.45
  • DLPN $2.00
  • Technical
  • Relative Strength Index (RSI)
  • ALLR 54.51
  • DLPN 50.40
  • Support Level
  • ALLR $0.80
  • DLPN $1.07
  • Resistance Level
  • ALLR $1.09
  • DLPN $1.24
  • Average True Range (ATR)
  • ALLR 0.07
  • DLPN 0.08
  • MACD
  • ALLR 0.02
  • DLPN -0.01
  • Stochastic Oscillator
  • ALLR 63.03
  • DLPN 23.81

About ALLR Allarity Therapeutics Inc.

Allarity Therapeutics Inc is a clinical-stage, precision medicine pharmaceutical company focused on developing novel anti-cancer therapeutics for patients with high unmet medical needs. The company is actively advancing the development of stenoparib, an orally available, small-molecule inhibitor for patients with advanced recurrent ovarian cancer. It is leveraging its proprietary Drug Response Predictor (DRP) technology to refine patient selection and improve clinical outcomes. The company operates as a single operating and reporting segment (developing a treatment for ovarian cancer) in two geographic areas: Denmark and the United States.

About DLPN Dolphin Entertainment Inc.

Dolphin Entertainment Inc is an independent entertainment marketing and production company. It provides strategic marketing and publicity services to many of the top brands, both individual and corporate, in the motion picture, television, music, gaming, culinary, hospitality, and lifestyle industries. It operates in two reportable segments: Entertainment publicity and marketing and Content production. It generates the majority of its revenue from the Entertainment publicity and marketing segment which provides clients with diversified marketing services, including public relations, entertainment and hospitality content marketing, strategic marketing consulting, and content production of marketing materials.

Share on Social Networks: